The nation of Zimbabwe has turned down a major US health deal valued at 367 million US dollars (£272m) over five years over the United States' demand for sensitive information.
This move was revealed after a internal memorandum dated December was disclosed, which showed President Emmerson Mnangagwa felt the deal was "unbalanced".
A government representative has since stated that the United States was seeking health data for research and profit but was unwilling to share the resulting advantages from any future vaccines.
"We are forced to start the challenging and unfortunate task of winding down our health aid in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont publicly.
The US Embassy said the United States had furnished over $1.9bn for health programmes to Zimbabwe over the last two decades.
A medical body in Zimbabwe has called for further negotiations to find a deal acceptable to both sides so the country's critical HIV programme can be sustained.
Broader Implications
This rejection follows a comparable case in Kenya, where a high court suspended a similar health funding agreement after legal challenges were raised about the safety of Kenyans' medical information.
Since resuming the presidency last year, US President Donald Trump has slashed foreign aid and closed the key foreign aid agency.
USAID had managed aid for the American government, but Trump claimed its spending was "inefficient" and his government was seeking direct bilateral deals to boost openness and accountability.
As per reports, Sixteen African countries have so far signed these new agreements, constituting over $18.3bn in committed funds.
Specifics of the Declined Deal
The funds for Zimbabwe would have gone towards "HIV/Aids treatment and prevention, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We are confident this cooperation would have delivered significant advantages for Zimbabwean communities, particularly the 1.2 million presently on antiretroviral therapy via US-supported programmes," Tremont commented.
However, official spokesman Nick Mangwana maintained the proposed deal was "asymmetrical".
"Zimbabwe was being asked to share its genetic material and health information over an extended period, with no corresponding promise of access to any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that might result from that provided information," his statement read.
"In essence, our nation would supply the raw materials for scientific discovery with no assurance that the resulting innovations would be available to our citizens should a new health crisis emerge."
National Interest and Global Health
Mangwana further pointed out that the American exit from the World Health Organization (WHO) and its pursuit of bilateral health agreements were undermining structures already established via the international organization.
Mangwana gave as an example its Pathogen Access and Benefit Sharing system designed to deal with future pandemics.
"This framework is designed to guarantee that when a country provides its samples, the resulting advantages – including vaccines and treatments – are shared equitably, not monopolised exclusively by those with the resources to develop them."
Zimbabwe's reservations regarding the US deal "are not meant as hostility towards the US," he added.
"We welcome continued discussions with our American counterparts on how subsequent collaboration could be designed in a manner that respects the sovereignty and dignity of each country."
Medical Community Reaction
Medical experts expressed it acknowledged the government's concerns, but urged that negotiations must proceed given that much of the nation's HIV programmes relied on foreign aid.
"In cases where technical issues arise, such as those relating to data governance or implementation frameworks, these can frequently be addressed through detailed discussion and mutually agreed protections," the group added.
This impasse underscores the ongoing challenges between accepting much-needed foreign assistance and safeguarding local interests in an ever more interconnected world.